A central event in the development of the allergic response is theinteraction between immunoglobulin E(IgE) and its cellular high-affinity receptor Fc
![](/images/gifchars/epsilon.gif)
RI.Allergen-bound IgE mediates the allergic response bybindingthrough its Fc region to its cellular receptor on mast cells andbasophils, causing the release of chemical mediators. One strategy for the treatment of allergic disorders is theuse of therapeutic compounds which would inhibit the interaction between IgE and Fc
![](/images/gifchars/epsilon.gif)
RI. Using astructure-based design approach, conformationally constrained synthetic peptides were designed to mimic a biologically active
![](/images/gifchars/beta2.gif)
-hairpin region of the
![](/images/gifchars/alpha.gif)
-chain of Fc
![](/images/gifchars/epsilon.gif)
RI.Two peptide mimics of the Fc
![](/images/gifchars/epsilon.gif)
RI
![](/images/gifchars/alpha.gif)
-chain were previously shownto inhibit IgE-Fc
![](/images/gifchars/epsilon.gif)
RI interactions, one a peptidecomprised of
L-amino acids, covalently cyclized by N- andC-terminal cysteine residues, and the other itsretroenantiomer. In this paper the solution structures of thesecompounds are derived using NMR spectroscopy.The topochemical relationship between the retroenantiomericcompounds and the structural basis of their biologicalactivity is described.